UBS Maintains Neutral on Cabot, Lowers Price Target to $98
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector maintains a Neutral rating on Cabot (NYSE:CBT) but lowers the price target from $103 to $98.
August 06, 2024 | 3:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UBS analyst Joshua Spector maintains a Neutral rating on Cabot (NYSE:CBT) and lowers the price target from $103 to $98.
The lowered price target from $103 to $98 by UBS suggests a less optimistic outlook for Cabot's stock performance, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100